High-Risk Patients Referred for Transcatheter Aortic Valve Implantation: Management and Outcomes Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H. Ryan, MD, Jill E. Fowler, RN, BSN, Shannon D. Hoffman, RN, Syma L. Prince, RN, BSN, Morley A. Herbert, PhD, Dan Culica, MD, PhD, Michael J. Mack, MD The Annals of Thoracic Surgery Volume 86, Issue 5, Pages 1450-1457 (November 2008) DOI: 10.1016/j.athoracsur.2008.07.043 Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Thirty-day mortality rates. (AVR = aortic valve replacement; O/E = observed/expected ratio.) The Annals of Thoracic Surgery 2008 86, 1450-1457DOI: (10.1016/j.athoracsur.2008.07.043) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan–Meier survival curves for treatment groups. (AVR = aortic valve replacement.) The Annals of Thoracic Surgery 2008 86, 1450-1457DOI: (10.1016/j.athoracsur.2008.07.043) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions